McKinley Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
McKinley Capital Management's DGX Position: Q2 2024 in Review
McKinley Capital Management sold out of Quest Diagnostics (DGX) in Q2 2024, closing a stake of 17,110 shares — an estimated $2.28M sold.
McKinley Capital Management first reported a position in DGX in Q4 2016 and held it in 20 quarters. The position peaked at $5.6M in Q4 2022. 838 funds tracked by Wall St. Rank hold DGX as of Q2 2024.
- McKinley Capital Management reported no remaining Quest Diagnostics position as of Q2 2024 after selling out during the quarter.
- McKinley Capital Management sold 17,110 Quest Diagnostics shares in Q2 2024, an estimated $2.28M.
- McKinley Capital Management first reported a position in Quest Diagnostics in Q4 2016 and held it in 20 quarters.
- McKinley Capital Management's Quest Diagnostics position peaked at $5.6M in Q4 2022.
- 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2024.
Based on McKinley Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.